Skip to main content

Cogent Biosciences, Inc.

COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001622229

In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Cogent Biosciences, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of COGT: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders862112+28
Shares47.2M33.1K70.3M+23.1M (+49.0%)
Value$353.6M$248.0K$633.3M+$280.0M (+79.2%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (41)

Institutions that held Cogent Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to COGT in Q2 2022
InstitutionSharesValue% of portfolio
Adage Capital Partners GP, L.L.C.1,226,650$11.1M0.03%
Balyasny Asset Management LLC1,101,303$9.93M0.04%
Kynam Capital Management, LP1,000,000$9.02M2.33%
Assenagon Asset Management S.A.988,636$8.92M0.04%
Cormorant Asset Management, LP750,000$6.76M0.52%
Suvretta Capital Management, LLC600,000$5.41M0.21%
Boxer Capital, LLC425,000$3.83M0.24%
EAM Investors, LLC365,667$3.30M0.81%
Parkman Healthcare Partners LLC288,750$2.60M0.96%
Ikarian Capital, LLC250,000$2.26M0.94%
Pura Vida Investments, LLC238,787$2.15M0.34%
Polar Asset Management Partners Inc.235,500$2.12M0.03%
Macquarie Group Ltd230,000$2.08M0.00%
D. E. Shaw & Co., Inc.195,901$1.77M0.00%
EAM Global Investors LLC181,581$1.64M0.40%
Connor, Clark & Lunn Investment Management Ltd.174,208$1.57M0.01%
Tekla Capital Management LLC146,911$1.32M0.05%
Affinity Asset Advisors, LLC125,000$1.13M0.62%
Ensign Peak Advisors, Inc51,138$461.0K0.00%
SEI Investments Co45,820$413.0K0.00%
Alliancebernstein L.P.39,700$358.0K0.00%
Susquehanna International Group, LLP35,345$319.0K0.00%
Boothbay Fund Management, LLC33,500$302.0K0.01%
Virtu Financial LLC30,063$271.0K0.02%
Caption Management, LLC23,000$207.0K0.02%
PEAK6 Investments LLC16,380$193.9K0.00%
SG Americas Securities, LLC17,049$154.0K0.00%
Values First Advisors, Inc.16,310$147.0K0.10%
LGL Partners, LLC14,500$131.0K0.02%
State Board of Administration of Florida Retirement System14,382$130.0K0.00%
Mirae Asset Global Investments Co., Ltd.11,613$105.0K0.00%
Bayesian Capital Management, LP11,615$105.0K0.02%
Walleye Capital LLC10,589$96.0K0.00%
Cutler Group LP7,494$67.0K0.01%
Group One Trading, L.P.4,600$41.0K0.00%
Venture Visionary Partners LLC2,000$18.0K0.00%
US Bancorp1,301$12.0K0.00%
Crewe Advisors LLC386$3.00K0.00%
Credit Suisse AG42$00.00%
Captrust Financial Advisors7$00.00%
Ronald Blue Trust, Inc.55$00.00%

Sold out (13)

Institutions that held Cogent Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held Cogent Biosciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding COGT in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC28,131$211.0K
Amalgamated Financial Corp.4,942$37.0K